The Swedish SCAN-B cohort, the HER2DX risk-score was found significantly associated with OS after adjustment for clinical variables and treatment regimen - ESMO Open

The Swedish SCAN-B cohort, the HER2DX risk-score was found significantly associated with OS after adjustment for clinical variables and treatment regimen – ESMO Open

ESMO Open posted on X:

“Hot off the press: among 757 patients with early HER2+ breast cancer in the Swedish SCAN-B cohort, the HER2DX risk-score as a continuous variable was found significantly associated with OS after adjustment for clinical variables and treatment regimen.”

The Swedish SCAN-B cohort, the HER2DX risk-score was found significantly associated with OS after adjustment for clinical variables and treatment regimen - ESMO Open

Read Further
Source: ESMO Open/X

Breast Cancer ESMO ESMO Open HER2 HER2DX risk-score OncoDaily Oncology Swedish SCAN-B cohort